FDA Inspection 750585 — Cipla Limited

Cipla Limited — FEI 3007021905

The FDA completed an inspection of Cipla Limited on Sep 22, 2011 in Mumbai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 22, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Mumbai (India)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
891221 CFR 314.81(b)(2)Timely submission

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.